MeghaBhumralkar Ph.D.

Patent Agent

Los Angeles +

Megha Bhumralkar's practice focuses on United States and foreign patent prosecution in the areas of biotechnology, chemistry, and pharmaceuticals. In addition, Megha is involved in preparation of noninfringement, invalidity, and freedom-to-operate opinions.

Before joining Jones Day, Megha was a technology specialist at the San Diego offices of Fish & Richardson and Hellar Ehrman. Prior to entering the intellectual property field, she was a postdoctoral research fellow at the University of California, San Diego where her research involved synthetic collagen mimetics. She worked extensively on small molecule heterocycles during her graduate studies.

Megha is a member of the American Chemical Society and the San Diego Intellectual Property Law Association.


  • MEI Pharma develops patent portfolio for small molecule PI3K delta inhibitorsJones Day represents MEI Pharma, Inc. in patent prosecution of small molecule PI3K delta inhibitors.
  • Ambit Biosciences develops patent portfolio for small molecule kinase inhibitor programsJones Day represented Ambit Biosciences in the development of patent portfolios related to small molecule kinase inhibitor programs and phage-displayed protein assays.